Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
Shyamala Maheswaran(Massachusetts General Hospital), Daniel A. Haber(Howard Hughes Medical Institute), Sunitha Nagrath(University of Michigan), Alona Muzikansky(Johns Hopkins University), Daphne W. Bell(National Institutes of Health), Brian W. Brannigan(Harvard University), Subba R. Digumarthy(Massachusetts General Hospital), A. John Iafrate(Massachusetts General Hospital), Sven Diederichs(University of Freiburg), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), Daniel Irimia(Shriners Hospitals for Children - Erie), Chey V. Collura(Harvard University), Elizabeth K. Inserra(Harvard University), Jeffrey Settleman(Enzo Life Sciences (United States)), Thomas J. Lynch(Nationwide Children's Hospital), Lindsey Ulkus(Harvard University), Ronald G. Tompkins(Nashville Oncology Associates)
Cited by 1,614
Related Papers
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k